The efficacy and safety of picosecond 1064 nm Nd:YAG laser in treatment of post sclerotherapy hyperpigmentation: a pilot study.
- Conditions
- post sclerotherapy hyperpigmentationthe complication of cosmetic sclerotherapy safety profile of using picosecond 1064 nm Nd:YAG laser in low-fluence non-ablative settingsclerotherapyhyperpigmentationlasersclerotherapy adverse effects
- Registration Number
- TCTR20210507005
- Lead Sponsor
- Institute of Dermatology, Thailand
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 12
1. Patient is diagnosed as post-sclerotherapy hyperpigmentation from sclerotherapy using 0.1- 1% polidocanol in liquid or foam solution. Off- treatment time is 3-months period.
2. No truncal reflux by Duplex ultrasound study.
3. The patient has 2 lesions or more.
4. Those lesions has similar melanin index.
5. Age > 18 years.
6. Fitzpatrick skin type III-V
7. Patient could make a visit as appointed
8. Patient has no history of using bleaching agents such as hydroquinone, retinoids prior to the study.
1. Patient is receiving anticoagulant, minocycline or iron supplements.
2. Patient has received laser treatment on the study sites within 6 months.
3. Pregnant patient
4. Patient with history of photosensitive conditions
5. Patient with history or risk of keloidal scar formation
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Mean melanin index at 4 weeks and 8 weeks after the intervention Mexameter
- Secondary Outcome Measures
Name Time Method Patient satisfactory score 4 weeks after the intervention Patient reported outcome using a 5-point rating scale questionnaire.,Physician evaluation score 4 weeks after the intervention Physician reported outcome using a 5-point rating scale questionnaire.